MétaCan
Menu
Back to cohort

Effect of age and temporal patterns over 5 years in a Magnetic Resonance Imaging (MRI)-based breast surveillance study for BRCA mutation carriers

2004· article· en· W2337473115 on OpenAlexaffabout
Ellen Warner, Donald B. Plewes, Kylie Hill, Petrina A. Causer, George Deboer, Steven A. Narod, M. Cutrara, Elizabeth Ramsay, Roberta A. Jong, Jennifer Wong

Bibliographic record

VenueJournal of Clinical Oncology · 2004
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenetics, Bioinformatics, and Biomedical Research
Canadian institutionsSunnybrook Health Science Centre
Fundersnot available
KeywordsMedicineBreast cancerMammographyBRCA mutationMagnetic resonance imagingCancerBreast MRIStage (stratigraphy)Internal medicineOncologyConfidence intervalGynecologyRadiology

Abstract

fetched live from OpenAlex

9500 Background: With mammography (M) –based screening for BRCA mutation carriers, interval cancer rates are 44–56% and node +ve rates are 23–56%. (Brekelmans JCO 2001, Scheuer JCO 2002). Breast MRI is more sensitive than M but less specific (Robson ASCO 2002), and a reduction in breast cancer mortality is yet unproven. Methods: Since 11/97 BRCA mutation carriers ages 25 to 65 have been enrolled in a 5 year surveillance study of annual M, ultrasound (US), MRI, and semi-annual clinical breast examination (CBE). Results: 279 women (57% BRCA1, 39% previously affected) have had at least 1 round of screening, with 30 screen-detected cancers in 29 women and only 1 interval cancer (3%). Overall sensitivity of MRI was 84%, M 32% (p=0.005), US 40%, CBE 7%. These differences in sensitivity were almost identical for the 14 women ≥ age 50 vs. 17 women < age 50 at diagnosis, and for the 10 in-situ (DCIS) vs. 21 invasive cancers, and did not vary significantly over the 5 years. (See table below.) Conclusions: 1. MRI is significantly more sensitive than mammography independent of age. 2. MRI specificity improves more than ultrasound over time and is acceptable after the 1st year. 3. The extremely low interval cancer rate and tumour stage compared to historical controls, and the decrease in cancer detection rate and tumour stage after the first screen, all predict that MRI-based surveillance will likely lower cancer mortality rates in BRCA mutation carriers. Author Disclosure Employment or Leadership Consultant or Advisory Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Canadian Breast Cancer Research Alliance; Amersham Health; (Canadian) National Breast Cancer Fund; (US) NIH

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.016

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.007
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.400
Teacher spread0.377 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2004
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicGenetics, Bioinformatics, and Biomedical ResearchFrench-language works237,207